WDB coco Co (TSE:7079) ROCE % : 42.22% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is WDB coco Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. WDB coco Co's annualized ROCE % for the quarter that ended in Dec. 2023 was 42.22%.

WDB coco Co ROCE % Historical Data

The historical data trend for WDB coco Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WDB coco Co ROCE % Chart

WDB coco Co Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

54.82

44.54

35.55

48.74

41.68

WDB coco Co Quarterly Data
	Mar18	Mar19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															50.75	31.69	32.23	38.60	42.22

WDB coco Co ROCE % Calculation

WDB coco Co's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	1087.896	/	( ( (3133.667 - 855.397)	+	(3660.927 - 719.116) )	/ 2 )
	=	1087.896	/	( (2278.27	+	2941.811)	/ 2 )
	=	1087.896	/	2610.0405
	=	41.68 %

WDB coco Co's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	1408.568	/	( ( (3919.637 - 691.824)	+	(4135.661 - 690.625) )	/ 2 )
	=	1408.568	/	( ( 3227.813	+	3445.036 )	/ 2 )
	=	1408.568	/	3336.4245
	=	42.22 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

WDB coco Co (TSE:7079) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

WDB coco Co ROCE % Related Terms

Thank you for viewing the detailed overview of WDB coco Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

WDB coco Co (TSE:7079) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » WDB coco Co Ltd (TSE:7079) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-8-11 Harumi, Chuo-ku, Triton Square Y 27th Floor, Tokyo, JPN, 104-6127

Website

https://www.wdbcoco.com

WDB coco Co Ltd is a provider of safety information management for the development of pharmaceuticals and medical devices. Its services include business related to safety information management, preparation of materials related to regulatory application, QC related work, PMS facility contract support related work, clinical research support / monitoring, and temporary staffing. The company provides Contract Research Organization services for all new drug developments such as monitoring, safety information, data management and statistical analysis. It provides support for the development of generic drugs such as bioequivalence studies and biosimilars, clinical research and physician-led clinical trials.

WDB coco Co (TSE:7079) Headlines

No Headlines